MATEON THERAPEUTICS INC | Business Finance | Business Contracts

Securities Purchase Agreement (Filed With SEC on June 27, 2022)

Convertible Promissory Note (Filed With SEC on June 27, 2022)

Securities Purchase Agreement (Filed With SEC on June 3, 2022)

Convertible Promissory Note (Filed With SEC on June 3, 2022)

Form of Unsecured Convertible Note Purchase Agreement (Filed With SEC on February 2, 2022)

Form of Convertible Promissory Note (Filed With SEC on February 2, 2022)

Form of Securities Purchase Agreement (Filed With SEC on December 1, 2021)

Form of Convertible Promissory Note (Filed With SEC on December 1, 2021)

Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC, dated October 25, etween Oncotelic Therapeutics, Inc. and... (Filed With SEC on October 28, 2021)

Promissory Note issued to Golden Mountain Partners, LLC, by Oncotelic Therapeutics, Inc., dated October 25, 2021 (Filed With SEC on October 28, 2021)

Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC, dated September 21, 2021 (Filed With SEC on September 27, 2021)

Promissory Note issued to Golden Mountain Partners, LLC, by Oncotelic Therapeutics, Inc., dated September 21, 2021 (Filed With SEC on September 27, 2021)

Term Sheet between Oncotelic Therapeutics, Inc. and Autotelic, Inc., dated August 31, 2021 (Filed With SEC on September 3, 2021)

Form of Convertible Promissory Note, issued by the Company under the Note Purchase Agreement dated as of August 4, 2021 (Filed With SEC on August 5, 2021)

Form of Note Purchase Agreement, dated as of August 4, 2021, by and among the Company and the investors identified therein (Filed With SEC on August 5, 2021)

Form of Subscription Agreement, dated May 25, 2021 (Filed With SEC on June 1, 2021)

Form of Note, dated May 25, 2021 (Filed With SEC on June 1, 2021)

Equity Purchase Agreement by and between Oncotelic Therapeutics, Inc., and Peak One Opportunity Fund, L.P., dated May 3, 2021 (Filed With SEC on May 7, 2021)

Registration Rights Agreement, by and between Oncotelic Therapeutics, Inc., and Peak One Opportunity Fund, L.P., dated May 3, 2020 (Filed With SEC on May 7, 2021)

Form of Subscription Agreement (Filed With SEC on March 26, 2021)

Form of Edgepoint Warrant (Filed With SEC on March 26, 2021)

Form of Mateon Warrant (Filed With SEC on March 26, 2021)

Form of Note (Filed With SEC on March 26, 2021)

Form of Registration Rights Agreement (Filed With SEC on March 26, 2021)

Loan, Secured Convertible Note Purchase, and Security Agreement between the Company and Golden Mountain Partners, LLC dated June 27, 2020 (Filed With SEC on November 16, 2020)

Secured Convertible Promissory Note between the Company and Golden Mountain Partners, LLC dated June 27, 2020 (Filed With SEC on November 16, 2020)

Form of Subscription Agreement, dated August 7, 2020 (Filed With SEC on August 13, 2020)

Form of Edgepoint Warrant, dated August 7, 2020 (Filed With SEC on August 13, 2020)

Form of Mateon Warrant, dated August 7, 2020 (Filed With SEC on August 13, 2020)

Form of Note, dated August 7, 2020 (Filed With SEC on August 13, 2020)

Form of Registration Rights Agreement, dated August 7, 2020 (Filed With SEC on August 13, 2020)

Form of Subscription Agreement, dated July 23, 2020 (Filed With SEC on July 29, 2020)

Form of Edgepoint Warrant, dated July 23, 2020 (Filed With SEC on July 29, 2020)

Form of Mateon Warrant, dated July 23, 2020 (Filed With SEC on July 29, 2020)

Form of Note, dated July 23, 2020 (Filed With SEC on July 29, 2020)

Registration Rights Agreement, dated July 23, 2020 (Filed With SEC on July 29, 2020)

NantCell Binding Termsheet (Filed With SEC on June 16, 2020)

Paycheck Protection Program Promissory Note dated April 21, 2020 between Mateon Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on April 27, 2020)

Form of Convertible Promissory Note, issued by the Company under the Note Purchase Agreement dated as of November 23, 2019 (Filed With SEC on November 25, 2019)

Form of Note Purchase Agreement, dated as of November 23, 2019, by and among the Company and the investors identified therein (Filed With SEC on November 25, 2019)

MATEON THERAPEUTICS INC (232) | Business Finance (48)